BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9825144)

  • 1. [Study of the inhibiting effect of the molecular complex yeast RNA-tilorone on HIV-1 reproduction in vitro].
    Karpov AV; Antonenko SV; Barbasheva EV; Spivak NIa
    Biull Eksp Biol Med; 1998 Oct; 126(10):433-5. PubMed ID: 9825144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of anti-HIV activity of the yeast RNA-tilorone molecular complex].
    Karpov AV; Antonenko SV; Barbasheva EV; Spivak NIa
    Vopr Virusol; 1997; 42(1):17-9. PubMed ID: 9103037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-inhibitory effect of a yeast RNA-tilorone molecular complex in cell cultures.
    Karpov AV; Zholobak NM; Spivak NY; Rybalko SL; Antonenko SV; Krivokhatskaya LD
    Acta Virol; 2001 Jun; 45(3):181-4. PubMed ID: 11774897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiherpetic effect of RNA-tilorone molecular complex in cell culture].
    Skrots'ka OI; Zholobak NM; Antonenko SV; Spivak MIa; Karpov OV
    Mikrobiol Z; 2007; 69(3):62-8. PubMed ID: 17682533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production of type I interferons in the body exposed to yeast RNA-tiloron molecular complexes].
    Karpov AV; Zholobak NM
    Vopr Virusol; 1996; 41(1):13-6. PubMed ID: 8669137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The inhibiting action of interferon inducers on the multiplication of the human immunodeficiency virus].
    Nosik NN; Nosik DN; Kuznetsova NV
    Vopr Virusol; 1992; 37(2):92-4. PubMed ID: 1441434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferonogenic activity of immobilized ribopolynucleotides in vitro].
    Zholobak NM; Mandzhos AP; Verevka SV; Povodzinskiĭ VM; Karpov AV
    Ukr Biokhim Zh (1999); 2003; 75(6):106-10. PubMed ID: 15143526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The interferonogenic properties of yeast RNA-tilorone complexes in a cell culture].
    Karpov AV; Zholobak NM
    Antibiot Khimioter; 1995 May; 40(5):20-3. PubMed ID: 8534174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative cytotoxic characteristics of the interferon-inducing yeast RNA-tilorone complex].
    Zholobak NM; Karpov AV; Rybalko SL; Antonenko SV; Barbasheva EV
    Antibiot Khimioter; 1999; 44(4):21-4. PubMed ID: 10483492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The depression of the reproduction of the human immunodeficiency virus by the use of Bogomolets antireticular cytotoxic serum].
    Spivak MIa; Karpov OV; Antonenko SV; Barbasheva OV; Kvielienkova KI; Voloshchenko IuV
    Mikrobiol Z; 1997; 59(5):57-61. PubMed ID: 9480019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin.
    Ouyang DY; Chan H; Wang YY; Huang H; Tam SC; Zheng YT
    Biochem Biophys Res Commun; 2006 Jan; 339(1):25-9. PubMed ID: 16289100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of interferonogenic molecular complex of yeast RNA--tilorone on DNA, RNA and protein synthesis in vitro].
    Karpov OV; Antonenko SV; Barbasheva OV; Kravchenko OM; Kysel'ova OK; Tkachikova L
    Ukr Biokhim Zh (1999); 2001; 73(2):33-8. PubMed ID: 11642041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysulfated sialic acid derivatives as anti-human immunodeficiency virus.
    Terada M; Fujita S; Suda I; Mastico R
    Biomed Pharmacother; 2005 Sep; 59(8):423-9. PubMed ID: 16143490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of HIV-1 replication inhibitors by using pseudotyped virus system].
    Cao YL; Guo Y
    Yao Xue Xue Bao; 2008 Mar; 43(3):253-8. PubMed ID: 18630260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of drugs based on native DNA against RNA and DNA containing viruses].
    Vaĭnberg IP; Nosik DN; Kaplina EN; Nosik NN; Kalnina LB; Lavrukhina LA
    Klin Med (Mosk); 1995; 73(6):3-5. PubMed ID: 8691775
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticarcinogenic and antimetastatic activity of interferon inducers of natural and synthetic origin with expressed antimutagenic properties].
    Zolotareva GN; KinzirskiAS ; Loginova NS; Galochkina ZI; Ershov FI
    Dokl Akad Nauk SSSR; 1991; 317(4):992-6. PubMed ID: 1954854
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interrelationship between the chain length of poly-L-lysine and the degree of protection of polyribonucleotide interferon inducers from human blood nucleases].
    Surzhik MA; Duks AE; Diatlova NG; Glazunov EA; Feldmane GIa; Timkovskiĭ AL
    Antibiot Khimioter; 1993 Jul; 38(7):21-5. PubMed ID: 8161271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-adenovirus activity of larifan in a cell culture].
    Nosach LN; Diachenko NS; Zhovnovataia VL; Butenko SI
    Mikrobiol Z; 1998; 60(3):80-4. PubMed ID: 9785803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo.
    Ho CC; Lin SS; Chou MY; Chen FL; Hu CC; Chen CS; Lu GY; Yang CC
    J Antimicrob Chemother; 2005 Aug; 56(2):372-9. PubMed ID: 16002419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.